VRK2 and pancreatic neoplasm: In pancreatic cancer, VRK2 phosphorylates and stabilizes cell cycle kinase Plk1, resulting in Plk1 overexpression to facilitate pancreatic cancer proliferation and chemotherapy resistance (65).